In the context of Streptococcus pneumoniae infection, deletion of TRAIL in mice reduces bacterial clearance in the lungs and worsens survival—an effect that is reversed by treatment with TRAIL or DR5 agonist antibody (70). This evidence concerns the gene TNFSF10 and pneumococcal infection.